Industry Research Reports
Home > Reports > Service & Software > Global Oncology Informatics Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Oncology Informatics Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-10-23
Pages: 141 Pages
Report ld: 5220312
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Oncology Informatics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Breast Cancer accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Oncology Informatics leading manufacturers including Cerner Corporation, Change Healthcare, Elekta AB, F.Hoffmann-La Roche Ltd., Hologic Inc., IBM Corporation, Inspirata Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, McKesson Corporation, etc., dominate supply; the top five capture approximately % of global revenue, with Cerner Corporation leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Oncology Informatics market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Cerner Corporation
- Change Healthcare
- Elekta AB
- F.Hoffmann-La Roche Ltd.
- Hologic Inc.
- IBM Corporation
- Inspirata Inc.
- Koninklijke Philips N.V.
- Laboratory Corporation of America Holdings
- McKesson Corporation
- MIM Software, Inc.
- Oncology Analytics, Inc.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Electronic Health Records (EHRs)
- Population Health Management (PHM)
- Clinical Decision Support System (CDSS)
- Drug Discovery and Development Informatics
Segment by Application
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Oncology Informatics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Oncology Informatics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Oncology Informatics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Electronic Health Records (EHRs)
1.2.3 Population Health Management (PHM)
1.2.4 Clinical Decision Support System (CDSS)
1.2.5 Drug Discovery and Development Informatics
1.3 Market Segmentation by Application
1.3.1 Global Oncology Informatics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Cervical Cancer
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oncology Informatics Revenue Estimates and Forecasts 2020-2031
2.2 Global Oncology Informatics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Oncology Informatics Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Oncology Informatics Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Electronic Health Records (EHRs) Market Size by Players
3.3.2 Population Health Management (PHM) Market Size by Players
3.3.3 Clinical Decision Support System (CDSS) Market Size by Players
3.3.4 Drug Discovery and Development Informatics Market Size by Players
3.4 Global Oncology Informatics Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Oncology Informatics Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Oncology Informatics Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Oncology Informatics Market Size by Type (2020-2031)
6.4 North America Oncology Informatics Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Oncology Informatics Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Oncology Informatics Market Size by Type (2020-2031)
7.4 Europe Oncology Informatics Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Oncology Informatics Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Oncology Informatics Market Size by Type (2020-2031)
8.4 Asia-Pacific Oncology Informatics Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Oncology Informatics Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Oncology Informatics Market Size by Type (2020-2031)
9.4 Central and South America Oncology Informatics Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Oncology Informatics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Oncology Informatics Market Size by Type (2020-2031)
10.4 Middle East and Africa Oncology Informatics Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Oncology Informatics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Cerner Corporation
11.1.1 Cerner Corporation Corporation Information
11.1.2 Cerner Corporation Business Overview
11.1.3 Cerner Corporation Oncology Informatics Product Features and Attributes
11.1.4 Cerner Corporation Oncology Informatics Revenue and Gross Margin (2020-2025)
11.1.5 Cerner Corporation Oncology Informatics Revenue by Product in 2024
11.1.6 Cerner Corporation Oncology Informatics Revenue by Application in 2024
11.1.7 Cerner Corporation Oncology Informatics Revenue by Geographic Area in 2024
11.1.8 Cerner Corporation Oncology Informatics SWOT Analysis
11.1.9 Cerner Corporation Recent Developments
11.2 Change Healthcare
11.2.1 Change Healthcare Corporation Information
11.2.2 Change Healthcare Business Overview
11.2.3 Change Healthcare Oncology Informatics Product Features and Attributes
11.2.4 Change Healthcare Oncology Informatics Revenue and Gross Margin (2020-2025)
11.2.5 Change Healthcare Oncology Informatics Revenue by Product in 2024
11.2.6 Change Healthcare Oncology Informatics Revenue by Application in 2024
11.2.7 Change Healthcare Oncology Informatics Revenue by Geographic Area in 2024
11.2.8 Change Healthcare Oncology Informatics SWOT Analysis
11.2.9 Change Healthcare Recent Developments
11.3 Elekta AB
11.3.1 Elekta AB Corporation Information
11.3.2 Elekta AB Business Overview
11.3.3 Elekta AB Oncology Informatics Product Features and Attributes
11.3.4 Elekta AB Oncology Informatics Revenue and Gross Margin (2020-2025)
11.3.5 Elekta AB Oncology Informatics Revenue by Product in 2024
11.3.6 Elekta AB Oncology Informatics Revenue by Application in 2024
11.3.7 Elekta AB Oncology Informatics Revenue by Geographic Area in 2024
11.3.8 Elekta AB Oncology Informatics SWOT Analysis
11.3.9 Elekta AB Recent Developments
11.4 F.Hoffmann-La Roche Ltd.
11.4.1 F.Hoffmann-La Roche Ltd. Corporation Information
11.4.2 F.Hoffmann-La Roche Ltd. Business Overview
11.4.3 F.Hoffmann-La Roche Ltd. Oncology Informatics Product Features and Attributes
11.4.4 F.Hoffmann-La Roche Ltd. Oncology Informatics Revenue and Gross Margin (2020-2025)
11.4.5 F.Hoffmann-La Roche Ltd. Oncology Informatics Revenue by Product in 2024
11.4.6 F.Hoffmann-La Roche Ltd. Oncology Informatics Revenue by Application in 2024
11.4.7 F.Hoffmann-La Roche Ltd. Oncology Informatics Revenue by Geographic Area in 2024
11.4.8 F.Hoffmann-La Roche Ltd. Oncology Informatics SWOT Analysis
11.4.9 F.Hoffmann-La Roche Ltd. Recent Developments
11.5 Hologic Inc.
11.5.1 Hologic Inc. Corporation Information
11.5.2 Hologic Inc. Business Overview
11.5.3 Hologic Inc. Oncology Informatics Product Features and Attributes
11.5.4 Hologic Inc. Oncology Informatics Revenue and Gross Margin (2020-2025)
11.5.5 Hologic Inc. Oncology Informatics Revenue by Product in 2024
11.5.6 Hologic Inc. Oncology Informatics Revenue by Application in 2024
11.5.7 Hologic Inc. Oncology Informatics Revenue by Geographic Area in 2024
11.5.8 Hologic Inc. Oncology Informatics SWOT Analysis
11.5.9 Hologic Inc. Recent Developments
11.6 IBM Corporation
11.6.1 IBM Corporation Corporation Information
11.6.2 IBM Corporation Business Overview
11.6.3 IBM Corporation Oncology Informatics Product Features and Attributes
11.6.4 IBM Corporation Oncology Informatics Revenue and Gross Margin (2020-2025)
11.6.5 IBM Corporation Recent Developments
11.7 Inspirata Inc.
11.7.1 Inspirata Inc. Corporation Information
11.7.2 Inspirata Inc. Business Overview
11.7.3 Inspirata Inc. Oncology Informatics Product Features and Attributes
11.7.4 Inspirata Inc. Oncology Informatics Revenue and Gross Margin (2020-2025)
11.7.5 Inspirata Inc. Recent Developments
11.8 Koninklijke Philips N.V.
11.8.1 Koninklijke Philips N.V. Corporation Information
11.8.2 Koninklijke Philips N.V. Business Overview
11.8.3 Koninklijke Philips N.V. Oncology Informatics Product Features and Attributes
11.8.4 Koninklijke Philips N.V. Oncology Informatics Revenue and Gross Margin (2020-2025)
11.8.5 Koninklijke Philips N.V. Recent Developments
11.9 Laboratory Corporation of America Holdings
11.9.1 Laboratory Corporation of America Holdings Corporation Information
11.9.2 Laboratory Corporation of America Holdings Business Overview
11.9.3 Laboratory Corporation of America Holdings Oncology Informatics Product Features and Attributes
11.9.4 Laboratory Corporation of America Holdings Oncology Informatics Revenue and Gross Margin (2020-2025)
11.9.5 Laboratory Corporation of America Holdings Recent Developments
11.10 McKesson Corporation
11.10.1 McKesson Corporation Corporation Information
11.10.2 McKesson Corporation Business Overview
11.10.3 McKesson Corporation Oncology Informatics Product Features and Attributes
11.10.4 McKesson Corporation Oncology Informatics Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 MIM Software, Inc.
11.11.1 MIM Software, Inc. Corporation Information
11.11.2 MIM Software, Inc. Business Overview
11.11.3 MIM Software, Inc. Oncology Informatics Product Features and Attributes
11.11.4 MIM Software, Inc. Oncology Informatics Revenue and Gross Margin (2020-2025)
11.11.5 MIM Software, Inc. Recent Developments
11.12 Oncology Analytics, Inc.
11.12.1 Oncology Analytics, Inc. Corporation Information
11.12.2 Oncology Analytics, Inc. Business Overview
11.12.3 Oncology Analytics, Inc. Oncology Informatics Product Features and Attributes
11.12.4 Oncology Analytics, Inc. Oncology Informatics Revenue and Gross Margin (2020-2025)
11.12.5 Oncology Analytics, Inc. Recent Developments
12 Oncology InformaticsIndustry Chain Analysis
12.1 Oncology Informatics Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Oncology Informatics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Oncology Informatics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Oncology Informatics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Oncology Informatics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Oncology Informatics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Oncology Informatics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Oncology Informatics Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Oncology Informatics Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Oncology Informatics Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Oncology Informatics by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Informatics as of 2024)
Table 11. Global Oncology Informatics Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Oncology Informatics Companies Headquarters
Table 13. Global Oncology Informatics Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Oncology Informatics Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Oncology Informatics Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Oncology Informatics Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Oncology Informatics Revenue by Application (2026-2031) & (US$ Million)
Table 21. Oncology Informatics High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Oncology Informatics Growth Accelerators and Market Barriers
Table 25. North America Oncology Informatics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Oncology Informatics Growth Accelerators and Market Barriers
Table 27. Europe Oncology Informatics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Oncology Informatics Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Oncology Informatics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Oncology Informatics Investment Opportunities and Key Challenges
Table 31. Central and South America Oncology Informatics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Oncology Informatics Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Oncology Informatics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Cerner Corporation Corporation Information
Table 35. Cerner Corporation Description and Major Businesses
Table 36. Cerner Corporation Product Features and Attributes
Table 37. Cerner Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Cerner Corporation Revenue Proportion by Product in 2024
Table 39. Cerner Corporation Revenue Proportion by Application in 2024
Table 40. Cerner Corporation Revenue Proportion by Geographic Area in 2024
Table 41. Cerner Corporation Oncology Informatics SWOT Analysis
Table 42. Cerner Corporation Recent Developments
Table 43. Change Healthcare Corporation Information
Table 44. Change Healthcare Description and Major Businesses
Table 45. Change Healthcare Product Features and Attributes
Table 46. Change Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Change Healthcare Revenue Proportion by Product in 2024
Table 48. Change Healthcare Revenue Proportion by Application in 2024
Table 49. Change Healthcare Revenue Proportion by Geographic Area in 2024
Table 50. Change Healthcare Oncology Informatics SWOT Analysis
Table 51. Change Healthcare Recent Developments
Table 52. Elekta AB Corporation Information
Table 53. Elekta AB Description and Major Businesses
Table 54. Elekta AB Product Features and Attributes
Table 55. Elekta AB Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Elekta AB Revenue Proportion by Product in 2024
Table 57. Elekta AB Revenue Proportion by Application in 2024
Table 58. Elekta AB Revenue Proportion by Geographic Area in 2024
Table 59. Elekta AB Oncology Informatics SWOT Analysis
Table 60. Elekta AB Recent Developments
Table 61. F.Hoffmann-La Roche Ltd. Corporation Information
Table 62. F.Hoffmann-La Roche Ltd. Description and Major Businesses
Table 63. F.Hoffmann-La Roche Ltd. Product Features and Attributes
Table 64. F.Hoffmann-La Roche Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. F.Hoffmann-La Roche Ltd. Revenue Proportion by Product in 2024
Table 66. F.Hoffmann-La Roche Ltd. Revenue Proportion by Application in 2024
Table 67. F.Hoffmann-La Roche Ltd. Revenue Proportion by Geographic Area in 2024
Table 68. F.Hoffmann-La Roche Ltd. Oncology Informatics SWOT Analysis
Table 69. F.Hoffmann-La Roche Ltd. Recent Developments
Table 70. Hologic Inc. Corporation Information
Table 71. Hologic Inc. Description and Major Businesses
Table 72. Hologic Inc. Product Features and Attributes
Table 73. Hologic Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Hologic Inc. Revenue Proportion by Product in 2024
Table 75. Hologic Inc. Revenue Proportion by Application in 2024
Table 76. Hologic Inc. Revenue Proportion by Geographic Area in 2024
Table 77. Hologic Inc. Oncology Informatics SWOT Analysis
Table 78. Hologic Inc. Recent Developments
Table 79. IBM Corporation Corporation Information
Table 80. IBM Corporation Description and Major Businesses
Table 81. IBM Corporation Product Features and Attributes
Table 82. IBM Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. IBM Corporation Recent Developments
Table 84. Inspirata Inc. Corporation Information
Table 85. Inspirata Inc. Description and Major Businesses
Table 86. Inspirata Inc. Product Features and Attributes
Table 87. Inspirata Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Inspirata Inc. Recent Developments
Table 89. Koninklijke Philips N.V. Corporation Information
Table 90. Koninklijke Philips N.V. Description and Major Businesses
Table 91. Koninklijke Philips N.V. Product Features and Attributes
Table 92. Koninklijke Philips N.V. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Koninklijke Philips N.V. Recent Developments
Table 94. Laboratory Corporation of America Holdings Corporation Information
Table 95. Laboratory Corporation of America Holdings Description and Major Businesses
Table 96. Laboratory Corporation of America Holdings Product Features and Attributes
Table 97. Laboratory Corporation of America Holdings Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Laboratory Corporation of America Holdings Recent Developments
Table 99. McKesson Corporation Corporation Information
Table 100. McKesson Corporation Description and Major Businesses
Table 101. McKesson Corporation Product Features and Attributes
Table 102. McKesson Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. McKesson Corporation Recent Developments
Table 104. MIM Software, Inc. Corporation Information
Table 105. MIM Software, Inc. Description and Major Businesses
Table 106. MIM Software, Inc. Product Features and Attributes
Table 107. MIM Software, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. MIM Software, Inc. Recent Developments
Table 109. Oncology Analytics, Inc. Corporation Information
Table 110. Oncology Analytics, Inc. Description and Major Businesses
Table 111. Oncology Analytics, Inc. Product Features and Attributes
Table 112. Oncology Analytics, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Oncology Analytics, Inc. Recent Developments
Table 114. Raw Materials Key Suppliers
Table 115. Distributors List
Table 116. Market Trends and Market Evolution
Table 117. Market Drivers and Opportunities
Table 118. Market Challenges, Risks, and Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology Informatics Product Picture
Figure 2. Global Oncology Informatics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Electronic Health Records (EHRs) Product Picture
Figure 4. Population Health Management (PHM) Product Picture
Figure 5. Clinical Decision Support System (CDSS) Product Picture
Figure 6. Drug Discovery and Development Informatics Product Picture
Figure 7. Global Oncology Informatics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Breast Cancer
Figure 9. Prostate Cancer
Figure 10. Colorectal Cancer
Figure 11. Cervical Cancer
Figure 12. Other
Figure 13. Oncology Informatics Report Years Considered
Figure 14. Global Oncology Informatics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 16. Global Oncology Informatics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Oncology Informatics Revenue Market Share by Region (2020-2031)
Figure 18. Global Oncology Informatics Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Electronic Health Records (EHRs) Revenue Market Share by Player in 2024
Figure 21. Population Health Management (PHM) Revenue Market Share by Player in 2024
Figure 22. Clinical Decision Support System (CDSS) Revenue Market Share by Player in 2024
Figure 23. Drug Discovery and Development Informatics Revenue Market Share by Player in 2024
Figure 24. Global Oncology Informatics Revenue Market Share by Type (2020-2031)
Figure 25. Global Oncology Informatics Revenue Market Share by Application (2020-2031)
Figure 26. North America Oncology Informatics Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Players Oncology Informatics Revenue (US$ Million) in 2024
Figure 28. North America Oncology Informatics Revenue (US$ Million) by Type (2020 - 2031)
Figure 29. North America Oncology Informatics Revenue (US$ Million) by Application (2020-2031)
Figure 30. US Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 31. Canada Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 32. Mexico Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 33. Europe Oncology Informatics Revenue YoY (2020-2031) & (US$ Million)
Figure 34. Europe Top 5 Players Oncology Informatics Revenue (US$ Million) in 2024
Figure 35. Europe Oncology Informatics Revenue (US$ Million) by Type (2020-2031)
Figure 36. Europe Oncology Informatics Revenue (US$ Million) by Application (2020-2031)
Figure 37. Germany Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 38. France Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 39. U.K. Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 40. Italy Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 41. Russia Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Oncology Informatics Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Top 8 Players Oncology Informatics Revenue (US$ Million) in 2024
Figure 44. Asia-Pacific Oncology Informatics Revenue (US$ Million) by Type (2020-2031)
Figure 45. Asia-Pacific Oncology Informatics Revenue (US$ Million) by Application (2020-2031)
Figure 46. Indonesia Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 47. Japan Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 48. South Korea Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 49. Australia Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 50. India Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 51. Indonesia Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 52. Vietnam Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 53. Malaysia Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 54. Philippines Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 55. Singapore Oncology Informatics Revenue (2020-2031) & (US$ Million)
Figure 56. Central and South America Oncology Informatics Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Central and South America Top 5 Players Oncology Informatics Revenue (US$ Million) in 2024
Figure 58. Central and South America Oncology Informatics Revenue (US$ Million) by Type (2020-2031)
Figure 59. Central and South America Oncology Informatics Revenue (US$ Million) by Application (2020-2031)
Figure 60. Brazil Oncology Informatics Revenue (2020-2025) & (US$ Million)
Figure 61. Argentina Oncology Informatics Revenue (2020-2025) & (US$ Million)
Figure 62. Middle East and Africa Oncology Informatics Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Middle East and Africa Top 5 Players Oncology Informatics Revenue (US$ Million) in 2024
Figure 64. South America Oncology Informatics Revenue (US$ Million) by Type (2020-2031)
Figure 65. Middle East and Africa Oncology Informatics Revenue (US$ Million) by Application (2020-2031)
Figure 66. GCC Countries Oncology Informatics Revenue (2020-2025) & (US$ Million)
Figure 67. Israel Oncology Informatics Revenue (2020-2025) & (US$ Million)
Figure 68. Egypt Oncology Informatics Revenue (2020-2025) & (US$ Million)
Figure 69. South Africa Oncology Informatics Revenue (2020-2025) & (US$ Million)
Figure 70. Oncology Informatics Industry Chain Mapping
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Oncology Informatics market?
The top companies in the global Oncology Informatics market are Cerner Corporation、Change Healthcare、Elekta AB.
Related Reports
Oncology Informatics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oncology Informatics was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 117
USD 3950.00
(Single User License)
Global Oncology Informatics Market Research Report 2026
The global Oncology Informatics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 114
USD 2900.00
(Single User License)
Global Oncology Informatics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oncology Informatics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 93
USD 4250.00
(Single User License)
Oncology Informatics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncology Informatics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 103
USD 3950.00
(Single User License)
Global Oncology Informatics Market Research Report 2025
The global market for Oncology Informatics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 83
USD 2900.00
(Single User License)
Global Oncology Informatics Market Insights, Forecast to 2030
Market Analysis and Insights: Global Oncology Informatics Market
Published Date: 2024-04-08
Pages: 108
USD 4900.00
(Single User License)
Oncology Informatics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Oncology Informatics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-22
Pages: 115
USD 3950.00
(Single User License)
Global Oncology Informatics Market Research Report 2024
The global Oncology Informatics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-06
Pages: 82
USD 2900.00
(Single User License)
Oncology Informatics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oncology Informatics was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 117
USD 3950.00 (Single User License)Global Oncology Informatics Market Research Report 2026
The global Oncology Informatics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 114
USD 2900.00 (Single User License)Global Oncology Informatics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oncology Informatics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 93
USD 4250.00 (Single User License)Oncology Informatics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncology Informatics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 103
USD 3950.00 (Single User License)Global Oncology Informatics Market Research Report 2025
The global market for Oncology Informatics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 83
USD 2900.00 (Single User License)Global Oncology Informatics Market Insights, Forecast to 2030
Market Analysis and Insights: Global Oncology Informatics Market
Published: 2024-04-08
Pages: 108
USD 4900.00 (Single User License)Oncology Informatics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Oncology Informatics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-22
Pages: 115
USD 3950.00 (Single User License)Global Oncology Informatics Market Research Report 2024
The global Oncology Informatics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-06
Pages: 82
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now